Entities / Company
Servier.
company in Madrid, Spain
- Reports this week
- 1
- Active events
- 2
- Connections
- 13
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Active this week
One to three months ago
-
Former president of the European Society of Cardiology (ESC) faced misconduct allegations regarding their tenure, which was affiliated with Imperial College London and involved drug trials.Some support3 reports
-
Insilico Medicine announced drug discovery collaborations with Eli Lilly and Servier.Some support2 reports
-
Servier acquired Day One Biopharmaceuticals and appointed Jeremy Bender to its Board of Directors.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Servier this week
News at the entities that move Servier mostConnections
The 4 strongest of 13, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Insilico Medicine Operational
The two companies are engaged in announced drug discovery collaborations.
-
Kim Fox Transactional
Kim Fox was involved in drug trials and profited from contracts with Servier.
-
European Society of Cardiology Structural
Servier's drug trial data influences ESC guideline recommendations, which in turn regulate drug use.
-
Ligand Pharmaceuticals Structural
The relationship is functional, based on assets acquired via a specific XOMA Royalty deal.